Clinical Trials Logo

Clinical Trial Summary

This is a Phase 1b/2, randomized, blinded, active-controlled study. Phase 1b will evaluate escalating doses of HTX-034 compared with bupivacaine HCl. Phase 2 will be a dose-expansion phase to evaluate additional subjects treated with the HTX-034 dose selected based on Phase 1b compared with bupivacaine HCl.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04398329
Study type Interventional
Source Heron Therapeutics
Contact
Status Completed
Phase Phase 1/Phase 2
Start date May 18, 2020
Completion date August 3, 2021

See also
  Status Clinical Trial Phase
Completed NCT02762929 - Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy Phase 2